Implantable biosensors are not yet at the developmental phase where they can be vital for personalized medicine, deconstructing healthcare as we see it today. However, the obstacles have been identified and multidisciplinary teams of researchers worldwide have been working to overcome the main technical problems that hamper their clinical application. TE strategies for implantable biosensors seem to be the way to tackle body’s immune rejection, since they can minimize the bodýs response by increasing their biocompatibility and reducing tissue mismatch, maintaining biosensor functionality for longer.

中文翻译：

---

用于个性化医疗的植入式生物传感器的展望

可植入生物传感器尚未处于发展阶段，它们对个性化医疗至关重要，可以解构我们今天所看到的医疗保健。然而，障碍已经确定，全球多学科研究人员团队一直在努力克服阻碍其临床应用的主要技术问题。用于植入式生物传感器的 TE 策略似乎是解决身体免疫排斥的方法，因为它们可以通过增加生物相容性和减少组织错配来最小化身体反应，从而更长时间地保持生物传感器的功能。